Safety of 2 recombinant human immunodeficiency virus type 1 (HIV-1) envelope vaccines in neonates born to HIV-1-infected women

C. K. Cunningham, D. W. Wara, M. Kang, T. Fenton, E. Hawkins, J. McNamara, L. Mofenson, A. M. Duliege, D. Francis, E. J. McFarland, W. Borkowsky, T. Hastings, N. Deygoo, M. Lugo, M. Rivera, K. Contello, S. Nachman, M. Davi, C. R. Salbenblatt, M. J. LevinR. Galvin, M. Mirochnick, A. Dorenbaum, S. A. Spector, W. M. Dankner, L. Frenkel, A. J. Melvin, K. M. Mohan, K. Mooney, C. Vincent, M. Silio, E. McBride, J. Pitt, P. LaRussa, E. G. Chadwick, D. F. Cloutier, J. Lambert, N. Hutton, B. Murante, S. Laverty, J. Sullivan, K. Luzuriaga, R. McKinney, M. Valentine, W. T. Shearer, M. Doyle

Research output: Contribution to journalArticlepeer-review

69 Scopus citations

Fingerprint

Dive into the research topics of 'Safety of 2 recombinant human immunodeficiency virus type 1 (HIV-1) envelope vaccines in neonates born to HIV-1-infected women'. Together they form a unique fingerprint.

Medicine & Life Sciences